Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0001193805-04-001193
Filing Date
2004-08-19
Accepted
2004-08-19 10:38:43
Documents
1
Period of Report
2004-08-16

Document Format Files

Seq Description Document Type Size
1 e400702_ex.html 3  
1 e400702_ex.xml 3 3004
  Complete submission text file 0001193805-04-001193.txt   4834
Mailing Address 111 BARCLAY BLVD STE 280 LINCOLNSHIRE IL 60069
Business Address 111 BARCLAY BLVD STE 280 LINCOLNSHIRE IL 60069
BIOSANTE PHARMACEUTICALS INC (Issuer) CIK: 0001023024 (see all company filings)

EIN.: 582301143 | State of Incorp.: WY | Fiscal Year End: 1231
SIC: 2836 Biological Products, (No Diagnostic Substances)

Mailing Address 850 THIRD AVENUE 21ST FLOOR NEW YORK NY 10022
Business Address 212-848-0849
Cho Michael (Reporting) CIK: 0001300949 (see all company filings)

Type: 3 | Act: 34 | File No.: 001-31812 | Film No.: 04985404